• Explore /
  • Poster
  • / Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma.

Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma.

Abstract Poster

Authors

null

Yaacov Richard Lawrence

Sheba Medical Center, Ramat Gan, Israel;

Yaacov Richard Lawrence , Sivan Lieberman , Ilanit Redinsky , Nir Honig , Einat Shacham-Shmueli , Naama Halpern , Stephen Raskin , Damien Urban , Aliza Ackerstein , Maoz Ben-Ayun , Katerina Shulman , Eitan Ben-Ami , Valeriya Semenisty , Ofer Purim , Nirit Yarom , Talia Golan , Ben Boursi , Lina Ziegler , Art M. Krieg , Ofer Margalit

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03507699

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 123)

DOI

10.1200/JCO.2023.41.4_suppl.123

Abstract #

123

Poster Bd #

F20

Abstract Disclosures

Similar Posters

First Author: Aparna Raj Parikh

First Author: Vanessa Anne Eulo

First Author: Jennifer Maria Johnson

First Author: Ahmad A. Tarhini